Bausch Change To Inventory from 2010 to 2026
| BHC Stock | USD 5.84 0.24 3.95% |
Change To Inventory | First Reported 1995-09-30 | Previous Quarter 7 M | Current Value 16 M | Quarterly Volatility 85.1 M |
Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 906.4 M, Interest Expense of 1.7 B or Selling General Administrative of 3 B, as well as many indicators such as Price To Sales Ratio of 0.34, Dividend Yield of 0.0534 or Days Sales Outstanding of 95.55. Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
Bausch | Change To Inventory | Build AI portfolio with Bausch Stock |
Analyzing Bausch Health's Change To Inventory over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change To Inventory has evolved provides context for assessing Bausch Health's current valuation and future prospects.
Latest Bausch Health's Change To Inventory Growth Pattern
Below is the plot of the Change To Inventory of Bausch Health Companies over the last few years. It is the increase or decrease in the amount of inventory a company has over a certain period. Bausch Health's Change To Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bausch Health's overall financial position and show how it may be relating to other accounts over time.
| Change To Inventory | 10 Years Trend |
|
Change To Inventory |
| Timeline |
Bausch Change To Inventory Regression Statistics
| Arithmetic Mean | (140,283,000) | |
| Geometric Mean | 62,072,393 | |
| Coefficient Of Variation | (78.60) | |
| Mean Deviation | 96,039,765 | |
| Median | (164,000,000) | |
| Standard Deviation | 110,260,017 | |
| Sample Variance | 12157.3T | |
| Range | 329M | |
| R-Value | (0.55) | |
| Mean Square Error | 9047.7T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | (12,004,912) | |
| Total Sum of Squares | 194516.3T |
Bausch Change To Inventory History
About Bausch Health Financial Statements
Bausch Health stakeholders use historical fundamental indicators, such as Bausch Health's Change To Inventory, to determine how well the company is positioned to perform in the future. Although Bausch Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bausch Health's assets and liabilities are reflected in the revenues and expenses on Bausch Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bausch Health Companies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change To Inventory | -240.3 M | -228.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out the analysis of Bausch Health Correlation against competitors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Will Pharmaceuticals sector continue expanding? Could Bausch diversify its offerings? Factors like these will boost the valuation of Bausch Health. Projected growth potential of Bausch fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bausch Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 13.68 | Earnings Share 0.97 | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bausch Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bausch Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bausch Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.